Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Nov 27;18(12):101141.
doi: 10.1016/j.waojou.2025.101141. eCollection 2025 Dec.

Global disparities in adrenaline access: A World Allergy Organization call for equity in anaphylaxis care

Mário Morais-Almeida  1 , Bryan L Martin  2 , Paul J Turner  3 , Alessandro Fiocchi  4 , Motohiro Ebisawa  5 , Gary Wing-Kin Wong  6 , Ignacio J Ansotegui  7 , Maryam Ali Al-Nesf Al-Mansouri  8 , Jonathan A Bernstein  9   10 , Hiroshi Chantaphakul  11   12 , Tinatin Chikovani  13 , Mary Beth Fasano  14 , Luz Fonacier  15 , Pedro Giavina-Bianchi  16 , René Maximiliano Gómez  17 , Sandra N González-Díaz  18 , Elham Hossny  19 , David M Lang  20 , Hideaki Morita  21 , José Antonio Ortegal Martell  22 , Nikolaos G Papadopoulos  23   24 , Luciana Kase Tanno  25   26   27
Affiliations
Editorial

Global disparities in adrenaline access: A World Allergy Organization call for equity in anaphylaxis care

Mário Morais-Almeida et al. World Allergy Organ J. .
No abstract available

Keywords: Access to care; Adrenaline / Epinephrine; Anaphylaxis; Disparities; Global health equity; Severe allergy; WHO essential medicines.

PubMed Disclaimer

Conflict of interest statement

Martin declares Speaker honorarium and advisory panel consultancy from Sanofi and Merck. Turner declares grants from UK Medical Research Council, the UK Food Standards Agency, The Jon Moulton Charity Trust, NIHR/Imperial Biomedical Research Centre, outside the submitted work; personal fees from UK Food Standards Agency, UpToDate, Elsevier and ALK outside the submitted work. Fiocchi has received Speaker honoraria and advisory panel consultancy outside the submitted work for Nutricia, Abbott, Danone, Stallergenes, DBV, Novartis. Funded research (Institution) from Sanofi, Novartis, Ferrero, DBV, GSK, Astrazeneca, Hipp GmBDH, Humana SpA. Ebisawa reports personal fees from Viatris and SAB of ARS-Pharmaceuticals, Novartis, and Sanofi outside the submitted work. Ansotegui reports personal fees from Bayer, Bial, Cipla, Eurodrug, Faes Farma, Gebro, Glenmark, Opella, Menarini, MSD, Roxall and Sanofi outside the submitted work. Bernstein reports Investigator and consultant fees from Novartis, Genentech, Sanofi, Regeneron, Celldex, Cogent, Blueprint Medicine, Telios, Astra Zeneca, GSK, Takeda/Shire, CSL Behring, Pharming, Biocyrst, Astria, Intellia, Kalvista, Pharvaris, Amgen, Areteia, Allergy therapeutics, Apogee, Opella, Ajou University, Kyowa Kirin, ARS, Eli Lilly, Escient, Evommune, Jasper, TEVA, and Yuhan; and speaker fees from Pharming, Kalvista, CSL Pharming. Fonacier has participated in the advisory board and/or consultant/speaker or received research grant paid to NYU Grossman Long Island School of Medicine from Regeneron, Sanofi, AstraZeneca, Dermavant, Blueprint. Giavina-Bianchi declares speaker honoraria from Novartis. Lang reports that he has served as a consultant for, carried out clinical research with, and/or has received honoraria from: AstraZeneca, Celldex, Genentech, Novartis, Sanofi-Regeneron. Morita reports consulting/advisory board agreements with Sanofi, LEO Pharma, and Otsuka Pharmaceutical Co., Ltd. Papadopoulos reports that he has served as a consultant for, carried out clinical research with, received grants from, and/or has received honoraria from: Abbott Nutrition, Berlin – Chemie AG, Danone, DBV Technologies, GSK, HAL Allergy, Hyproca Nutrition, MED Maps SRL, Menarini, Nestle Nutrition Institute, Numil, Regneron, Vianex, Vibrant America. All other authors have no conflict of interest within the scope of the submitted work (Morais-Almeida, Wong, Al-Nesf, Chantaphakul, Chikovani, Fasano, Gómez, González-Díaz, Hossny, Ortega-Martell, Tanno).

References

    1. Cardona V., Ansotegui I.J., Ebisawa M., et al. WAO Anaphylaxis guidance 2020. World Allergy Organ J. 2020;13 doi: 10.1016/j.waojou.2020.100472. - DOI - PMC - PubMed
    1. Dribin T.E., Muraro A., Camargo CA Jr, et al. GA(2)LEN Anaphylaxis Study Team. Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report - a GA2LEN project. J Allergy Clin Immunol. 2025:S0091–S6749. doi: 10.1016/j.jaci.2025.01.021. - DOI - PMC - PubMed
    1. Tanno L.K., Worm M., Ebisawa M., et al. Global availability of epinephrine autoinjectors. World Allergy Organ J. 2023;16 doi: 10.1016/j.waojou.2023.100821. - DOI - PMC - PubMed
    1. Dribin T.E., Waserman S., Turner P.J. Who needs epinephrine? Anaphylaxis, autoinjectors, and parachutes. J Allergy Clin Immunol Pract. 2023;11:1036–1046. doi: 10.1016/j.jaip.2023.02.002. - DOI - PMC - PubMed
    1. Arasi S., Morais Almeida M., Martin B., et al. Food Allergy Severity across the world: a world allergy organization international survey. World Allergy Organ J. 2025;18 doi: 10.1016/j.waojou.2025.101123. - DOI - PMC - PubMed

Publication types

LinkOut - more resources